產(chǎn)品展廳收藏該商鋪

您好 登錄 注冊(cè)

當(dāng)前位置:
上海恒遠(yuǎn)生物科技有限公司>技術(shù)文章>人CXC趨化因子配體2(CXCL2)ELISA試劑盒引用文獻(xiàn)

技術(shù)文章

人CXC趨化因子配體2(CXCL2)ELISA試劑盒引用文獻(xiàn)

閱讀:970          發(fā)布時(shí)間:2022-1-4

【文獻(xiàn)標(biāo)題】CXCL2-mediated ATR/CHK1 signaling pathway and?platinum resistance in?epithelial ovarian cancer

【作者】Sipei Nie, Yicong Wan, Hui Wang,et.al

【作者單位】南京醫(yī)科大學(xué)(Nanjing Medical University)

【文獻(xiàn)中引用產(chǎn)品】

人CXC趨化因子配體2(CXCL2)ELISA試劑盒

【關(guān)鍵詞】Epithelial ovarian cancer (EOC), Platinum-resistance, Chemokine, CXCL2

【DOI】doi.org/10.1186/s13048-021-00864-3

出版期刊】《RESEARCH》

【產(chǎn)品原文引用】

Enzyme?linked immunosorbent assay (ELISA)

Serum samples of platinum-resistant and platinum-sensitive patients and cell culture supernatants were respectively extracted for cytokine analysis. Human CXCL2 ELISA kits were purchased from Hengyuan? Biological Co. Ltd (Shanghai, China), and ELISA assay was performed as the manufacturers’ instructions. Each sample was duplicated.


收藏該商鋪

請(qǐng) 登錄 后再收藏

提示

您的留言已提交成功!我們將在第一時(shí)間回復(fù)您~

對(duì)比框

產(chǎn)品對(duì)比 產(chǎn)品對(duì)比 聯(lián)系電話 二維碼 意見(jiàn)反饋 在線交流

掃一掃訪問(wèn)手機(jī)商鋪
13564766906
在線留言